Research work · 2026

Quality Of Life Assessment in Head and Neck Cancer Patients Undergoing Radiation Therapy in a Tertiary Referral University Hospital

OncoDaily Medical Journal

Abstract

Introduction: There is considerable post-treatment morbidity in survivors of head and neck cancer (HNC) despite improved survival following multimodality therapy. Assessment of health-related quality of life (HR-QoL) gives valuable information about functional and psychosocial sequelae of radiation therapy (RT), especially in less-studied populations like South Asians. Methodology: A prospective observational study was conducted between August 2023 and December 2024, including biopsy-proven HNC patients receiving curative-intent RT (definitive or adjuvant). The EORTC QLQ-HN35 questionnaire (Urdu/English, interviewer-assisted) was administered at baseline and 12 ± 2 weeks post-RT. Mean ± SD were calculated for each domain. Pre- and post-treatment differences were analyzed using paired t-tests, while multivariate analysis (GLM-MANOVA) identified factors associated with HR-QoL outcomes. Results: Fifty-six patients (mean age, 49 ± 13 years; male sex, 78.6%) were included in the analysis. There was a marked deterioration of xerostomia (p = 0.004), pain (p = 0.011) and taste/smell (p = 0.018), whereas social contacts (p = 0.048) and sexuality (p < 0.001) improved after therapy. Tumor site (p < 0.001), histological subtype (p < 0.001) and marital status (p < 0.001) were the main HR-QoL predictors detected. Both oropharyngeal/hypopharyngeal locations were related to more post-treatment pain and social-eating problems. Conclusion: Within three months after curative-intent RT, HNC patients showed worsening of xerostomia, pain, and sensory loss, with improvement in social contact and sexuality. Tumor site, histopathology, and marital status were key predictors of HR-QoL, demonstrating anatomical, biological, and psychosocial influences. Targeted follow-up and supportive care are important for future studies integrating patient-reported and objective outcomes to personalize survivorship care.

DOI: 10.69690/odmj-018-3101-6898